Norann Zaghloul, Ph.D.
Responsibilities & Activities
My primary interest is in understanding the genetic underpinnings of type 2 diabetes and related metabolic disorders. My portfolios include projects in genetics and genomics of T2D which seek to identify genes and pathways contributing to T2D and its complications, including efforts to better define heterogeneity of T2D using genomic and other approaches. I am also responsible for projects related to functional genomic modeling of T2D and metabolic disorders in model organisms, including mammalian and non-mammalian systems. My portfolio also includes projects investigating mechanistic links between exocrine and endocrine pancreas in the context of diabetes.
I also serve as the Co-Chair and Program Officer for the Accelerating Medicines Partnership® program for Common Metabolic Diseases (AMP CMD).
Research Programs
Accelerating Medicines Partnership® Program for Common Metabolic Diseases (AMP® CMD)
A collaborative partnership between the NIDDK, FNIH, pharmaceutical companies, and nonprofit organizations to develop new models for identifying and validating promising biological targets to serve as biomarkers and/or for drug discovery.
Diabetes Genetics & Genomics
Genetic mechanisms underlying type 1 and type 2 diabetes and how genetic and epigenetic variation influences the metabolism of therapeutics.
Select Experience
Assistant/Associate Professor, Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, 2010-2019
Postdoctoral Fellow, Institute of Genetic Medicine, The Johns Hopkins University, 2006-2010
Ph.D., Genetics, The George Washington University, 2006